Product Reports Resources Pricing Login Book a demo

Precigen

Biotech & Life Sciences · Germantown, United States · Founded 1998 · IPO 2013

Biologically-based products that improve the quality of life and the health of the planet

Valuation $2.28B
Revenue $9.7M

Talent graph

Precigen's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 7 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

2 investors on Precigen's cap table

Sourced from Dealroom's funding and investor records.

Series B+ 2 investors entered at this stage
NewVa Capital Partners
Third Security LLC

Global footprint

Where Precigen has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
7.3K monthly visits
across markets
🇺🇸 United States58.9%
🇬🇧 United Kingdom21.9%
🇮🇳 India15.1%
🇩🇪 Germany2.7%
Top 4 markets shown

Patent intelligence

Precigen’s patent portfolio

Estimated portfolio value
$140M

100 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Capital deployed

Precigen's 3 investments and acquisitions.

Every disclosed deal where Precigen appeared as a backer or acquirer, 2015–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Precigen's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Precigen's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Precigen

        An AI-synthesized read of the highest-engagement posts about Precigen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Precigen on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.